Related Experiment Videos
A comparative study of Legionella micdadei and other nosocomial acquired pneumonia
Abstract:
The clinical and laboratory characteristics of 27 patients during an outbreak of pneumonia due to Legionella micdadei were reviewed. These patients were compared with a group of 46 patients who had other causes of nosocomial acquired pneumonia. Patients with pneumonia due to L micdadei typically had nosocomial acquisition of the disease and were immunosuppressed. Symptoms, physical findings, and laboratory tests were nonspecific; however, patients with pneumonia due to L micdadei had an increased frequency of pleuritic pain in the chest, dyspnea, cough, and changes in mental status compared to the nosocomial group. Direct fluorescent antibody staining and culture of sputum and other respiratory secretions established the diagnosis of infection with L micdadei. Unusual features included dual infections in three patients and pulmonary cavitation in five patients. Therapy with erythromycin, when instituted early, decreased mortality. Trimethoprim-sulfamethoxazole, used as alternative therapy in patients with persistent infection, was also curative. Because of the high mortality associated with a delay in diagnosis, it is important to consider the diagnosis of pneumonia due to L micdadei in immunosuppressed patients.
Insights
Legionella micdadei pneumonia, often hospital-acquired in immunosuppressed patients, presents with nonspecific symptoms. Early erythromycin treatment significantly reduces mortality in these Legionella micdadei infections.
Area of Science:
- Clinical Microbiology
- Infectious Diseases
- Pulmonology
Background:
- Legionella micdadei is an uncommon cause of pneumonia.
- Nosocomial pneumonia poses a significant health risk, especially in vulnerable populations.
Purpose of the Study:
- To review the clinical and laboratory features of Legionella micdadei pneumonia during an outbreak.
- To compare L. micdadei pneumonia patients with those having other nosocomial pneumonias.
- To identify key diagnostic and therapeutic strategies for L. micdadei infections.
Main Methods:
- Retrospective review of 27 patients with Legionella micdadei pneumonia.
- Comparison with 46 patients diagnosed with other nosocomial pneumonias.
- Diagnostic confirmation via direct fluorescent antibody staining and sputum culture.
Main Results:
- L. micdadei pneumonia typically occurred in immunosuppressed patients with nosocomial acquisition.
- Nonspecific symptoms were noted, but pleuritic pain, dyspnea, cough, and altered mental status were more frequent.
- Unusual findings included dual infections and pulmonary cavitation.
- Early erythromycin therapy reduced mortality; trimethoprim-sulfamethoxazole was effective for persistent cases.
Conclusions:
- Legionella micdadei pneumonia should be considered in immunosuppressed patients, particularly those with nosocomial infections.
- Prompt diagnosis and treatment, especially with erythromycin, are crucial for improving outcomes.
- Awareness of potential complications like dual infections and cavitation is important.